You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MSB0010718C

Showing 26 - 50 of 124
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors Trial in Darmstadt (Avelumab 3 mg/kg, Avelumab 10 mg/kg, Avelumab 20 mg/kg)

Completed
Has Results
  • Solid Tumors
  • Avelumab 3 mg/kg
  • +2 more
  • Darmstadt, Germany
    Research site
Sep 29, 2020

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

Terminated
Has Results
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 29, 2020

Squamous Cell Carcinoma of the Head and Neck (SCCHN), Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial in Worldwide

Terminated
Has Results
  • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • Rochester, New York
  • +4 more
Sep 17, 2021

Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or

Completed
  • Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
  • Avelumab Phase 1b
  • +3 more
  • Fayetteville, Arkansas
  • +57 more
Jan 18, 2023

Pancreatic Cancer Trial in Belgium, Singapore, United States (Avelumab, Binimetinib, Talazoparib)

Terminated
Has Results
  • Pancreatic Cancer
  • Fayetteville, Arkansas
  • +17 more
Dec 28, 2021

Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Stage II Bladder Cancer AJCC v8, Stage II Renal Pelvis Cancer

Completed
Has Results
  • Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall
  • +11 more
  • Scottsdale, Arizona
  • +2 more
Mar 12, 2021

Advanced Cancer Trial in Worldwide (Avelumab, Utomilumab, PF-04518600)

Active, not recruiting
  • Advanced Cancer
  • Encinitas, California
  • +87 more
Dec 7, 2022

Metastatic Colorectal Cancer Trial in Seoul (Avelumab)

Unknown status
  • Metastatic Colorectal Cancer
  • Seoul, Songpa, Korea, Republic of
    Asan Medical Center
Apr 1, 2020

Bladder Cancer, Metastatic Bladder Cancer, Invasive Bladder Cancer Trial in Houston (Avelumab)

Terminated
Has Results
  • Bladder Cancer
  • +2 more
  • Houston, Texas
  • +2 more
Aug 7, 2020

DLBCL Trial in Worldwide (biological, other, drug)

Terminated
Has Results
  • Diffuse Large B-Cell Lymphoma
  • Avelumab
  • +6 more
  • Duarte, California
  • +29 more
Nov 20, 2020

Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Infiltrating Renal Pelvis and Ureter Urothelial Carcinoma, Stage

Recruiting
  • Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall
  • +2 more
  • Therapeutic Conventional Surgery
  • +3 more
  • Aurora, Colorado
  • +82 more
Jan 24, 2023

Carcinoma, Hepatocellular Trial in Japan (Avelumab (MSB0010718C), Axitinib (AG-013736))

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Avelumab (MSB0010718C)
  • Axitinib (AG-013736)
  • Nagoya, Aichi, Japan
  • +6 more
Sep 1, 2020

NSCLC, Urothelial Cancer Trial in Worldwide (Avelumab (MSB0010718C), Axitinib (AG-013736))

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Urothelial Cancer
  • Avelumab (MSB0010718C)
  • Axitinib (AG-013736)
  • Glendale, Arizona
  • +36 more
Aug 16, 2022

NSCLC, Urothelial Cancer Trial in Worldwide (Avelumab 800 mg in combination with pemetrexed / carboplatin, Avelumab 800 mg in

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • Urothelial Cancer
  • Avelumab 800 mg in combination with pemetrexed / carboplatin
  • +3 more
  • Tucson, Arizona
  • +45 more
Oct 13, 2022

Solid Tumors Trial in Worldwide (Avelumab)

Completed
Has Results
  • Solid Tumors
  • Goodyear, Arizona
  • +73 more
Oct 26, 2021

Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Trial in Fuenlabrada, Madrid (PEGylated Recombinant Human Hyaluronidase

Terminated
  • Pancreatic Ductal Adenocarcinoma
  • Pancreatic Cancer
  • PEGylated Recombinant Human Hyaluronidase (PEGPH20)
  • Avelumab
  • Fuenlabrada, Madrid, Spain
  • +2 more
Aug 20, 2019

Triple Negative Breast Tumors Trial in Italy, United Kingdom (MSB0010718C)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • MSB0010718C
  • Bergamo, BG, Italy
  • +71 more
Mar 31, 2022

Advanced Bladder Urothelial Carcinoma, Advanced Renal Pelvis Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma Trial in

Recruiting
  • Advanced Bladder Urothelial Carcinoma
  • +17 more
  • Auburn, California
  • +111 more
Aug 17, 2022

Carcinoma, Squamous Cell of Head and Neck Trial in Amsterdam (avelumab, radiotherapy, cetuximab)

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek
Dec 10, 2019

Nasopharyngeal Cancer Trial in La Jolla, Boston (Avelumab)

Terminated
Has Results
  • Nasopharyngeal Cancer
  • La Jolla, California
  • +1 more
Aug 15, 2019

Prostate Cancer Trial run by the National Cancer Institute (NCI) (PROSTVAC-V, PROSTVAC-F, MSB0011359C (M7824))

Recruiting
  • Prostate Cancer
  • PROSTVAC-V
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8

Terminated
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Bintrafusp Alfa
  • Eribulin Mesylate
  • Houston, Texas
  • +1 more
Oct 27, 2022

Locally Advanced Intrahepatic Cholangiocarcinoma, Metastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

Recruiting
  • Locally Advanced Intrahepatic Cholangiocarcinoma
  • +5 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Hodgkins Lymphoma Trial in Italy, United Kingdom, United States (Avelumab)

Terminated
Has Results
  • Hodgkins Lymphoma
  • Duarte, California
  • +12 more
Apr 3, 2020

Breast Cancer Trial in Washington, Charlotte, Salt Lake City (Talazoparib, Avelumab)

Active, not recruiting
  • Breast Cancer
  • Washington, District of Columbia
  • +1 more
Oct 10, 2022